Free Trial
→ Read now. Do not delete. You’ve been warned. (From Porter & Company) (Ad)tc pixel Free BIVIW Stock Alerts

BioVie (BIVIW) Competitors

BioVie logo
$0.29 -0.05 (-14.18%)
Closing price 06/5/2026 03:55 PM Eastern
Extended Trading
$0.25 -0.05 (-15.46%)
As of 06/5/2026 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BIVIW vs. SXTPW, DRTSW, APLMW, CDIOW, and CELUW

Should you buy BioVie stock or one of its competitors? MarketBeat compares BioVie with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BioVie include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does BioVie compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, media sentiment, institutional ownership and valuation.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than BioVie. MarketBeat recorded 1 mentions for 60 Degrees Pharmaceuticals and 0 mentions for BioVie. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats BioVie on 2 of the 2 factors compared between the two stocks.

How does BioVie compare to Alpha Tau Medical?

BioVie (NASDAQ:BIVIW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

In the previous week, BioVie's average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
BioVie Neutral
Alpha Tau Medical Neutral

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

BioVie and Alpha Tau Medical tied by winning 0 of the 0 factors compared between the two stocks.

How does BioVie compare to Apollomics?

BioVie (NASDAQ:BIVIW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, dividends, risk, institutional ownership, media sentiment, valuation, profitability and analyst recommendations.

In the previous week, BioVie's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Apollomics beats BioVie on 1 of the 1 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Cardio Diagnostics Neutral

Summary

Cardio Diagnostics beats BioVie on 1 of the 1 factors compared between the two stocks.

How does BioVie compare to Celularity?

Celularity (NASDAQ:CELUW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

In the previous week, Celularity's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Celularity Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
BioVie N/A N/A N/A

Summary

Celularity beats BioVie on 1 of the 1 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVIW vs. The Competition

Export
MetricBioVieBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$461.60M$6.48B$12.46B
Dividend YieldN/A3.87%2.67%5.34%
P/E RatioN/A3.1423.9323.64
Price / SalesN/A6,606.57517.19112.93
Price / CashN/A13.1342.3557.17
Price / BookN/A83.479.736.37
Net IncomeN/A-$96.07M$3.56B$337.36M
7 Day Performance-16.86%-1.93%-2.91%-2.38%
1 Month Performance-3.32%1.04%-0.84%-0.57%
1 Year PerformanceN/A64.71%22.24%25.53%

BioVie Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVIW
BioVie
N/A$0.29
-14.2%		N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-14.4%		N/A-23.1%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.80
+17.6%		N/A+805.0%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+1.5%		N/A-37.6%$0.00$8.50MN/A59
CDIOW
Cardio Diagnostics
N/A$0.01
-0.8%		N/A-18.2%$0.00$16.57KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:BIVIW) was last updated on 6/6/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to get into the SpaceX IPO before June 12
Former tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...
Brownstone Research | Sponsoredtc pixel
In 30 days, you'll wish you'd read this email
A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...
Behind the Markets | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
She called ASTS before it ran 133%. Here's the system behind it.
Danielle Shay called AST SpaceMobile on Fox Business before it ran 133% - and found NBIS at $54 before it gapp...
Simpler Trading | Sponsoredtc pixel
Why is this free?
Simple Options Trading For Beginners normally sells for $29.97 - but right now Bill Poulos has opened a free w...
Profits Run | Sponsoredtc pixel
You own these two timebombs — and can’t sell them
Two blue-chip stocks with a combined $100 billion market cap are sitting inside VOO, SPY, FXAIX, and virtually...
Porter & Company | Sponsoredtc pixel